Perfluorochemicals in Vascular Medicine

Lowe K. C. Blood transfusion or blood substitution? Vox Sang 1986; 51: 257–63.

Riess J. G. Blood substitutes: Where do we stand at present with the fluorocarbon approach? Curr Surg 1988; 45: 365–70.

Sargent J W Seffl R. J. Properties of perfluorinated liquids. Fed Proc 1970; 29: 1699–703.

Riess J G Le Blanc M. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure Appl Chem 1982; 54: 2383–406.

Riess J G Le Blanc M. Preparation of perfluorochemical emulsions for biomedical use: Principles, materials and methods. In: Lowe K C ed. Blood substitutes: Preparation, physiology and medical applications. Chichester: Ellis Horwood, 1988: 94–129.

Howlett S. Dundas D. Sabiston D. C. Fluid fluorocarbon as oxygenator in experimental extracorporeal circulation. Arch Surg 1965; 91: 643–45.

Biro G P Blais P. Perfluorocarbon blood substitutes. CRC Crit Rev Oncol Hematol 1987; 6: 311–74.

Dellacherie E. Labrude P. Vigneron C. Riess J. G. Synthetic carriers of oxygen. CRC Crit Rev Ther Drug Carr Syst 1987; 3: 41–94.

Sharma S K Lowe K C Davis S. S. Emulsification methods for perfluorochemicals. Drug Dev Ind Pharm 1988; 14: 2371–76.

Magdassi S. Siman-Tov A. Formation and stabilisation of perfluorocarbon emulsions. Int J Pharm 1990; 59: 69–72.

Riess J. G. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater Artif Cells Immobil Biotechnol 1992; 20: 183–202.

Naito R. Yokoyama K. Perfluorochemical blood substitutes, Tech. Inform. Ser. No. 5. Osaka: Green Cross, 1978.

Makowski H. Tenschev P. Frey P. Necek S. Bergmann H. Blauhut B. Tolerance of an oxygen carrying colloidal blood substitute in human beings. In: Proceedings of the IVth International Symposium on Perfluorochemical Blood Substitutes. Amsterdam: Excerpta Medica, 1978: 47–50.

Ohyanagi H. Toshima K. Sekita M. . Clinical studies of perfluorochemical whole-blood substitutes: Safety of Fluosol-DA (20%) in normal human volunteers. Clin Ther 1979; 2: 306–12.

Mitsuno T. Ohyanagi H. Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA). Ann Surg 1982; 195: 60–69.

Vercellotti G M Hammerschmidt D E Craddock P R Jacobs H. S. Activation of plasma complement by perfluorocarbon artificial blood: Probable mechanism of adverse reactions in treated patients and rationale for corticosteroid prophylaxis. Blood 1982; 59: 1299–304.

Marwick C. FDA committee questions Fluosol efficacy; US approval not imminent. JAMA 1983; 250: 2585–86.

Gould S A Rosen A L Sehgal L R . Fluosol-DA as a red cell substitute in acute anemia. N Engl J Med 1986; 314: 1653–56.

Spence R K McCoy S. Costabile J. . Fluosol-DA-20 in the treatment of severe anemia: Randomized, controlled study of 46 patients. Crit Care Med 1990; 18: 1227–30.

Spence R K McCoy S. Costabile J. . Fluosol-DA 20% in the treatment of severe anemia: Ongoing studies in 52 patients. Biomater Artif Cells Immobil Biotechnol 1992; 20: 1069.

Vercellotti G M Hammerschmidt D. E. Human studies involving perfluorochemical emulsions. In: Lowe K C ed. Blood substitutes: Preparation, physiology and medical applications. Chichester: Ellis Horwood, 1988: 173–83.

FDC Rep, 8 January 1990: 8.

Xiong R. Zhang R A Chen H F Huang W Y Luo C P Cao W. T. Primary report on 10 clinical applications of perfluorocarbon artificial blood. Chin J Surg 1981; 19: 213–15.

Beloyartsev F F Mayevsky E I Islamov B. I. Ftorosan oxygen carrying perfluorochemical plasma substitute. Pushchino: Academy of Sciences of the USSR, 1983.

Chen H S Yang Z. H. Perfluorocarbon as blood substitute in clinical applications and in war casualties. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 403–409.

Lowe K. C. Perfluorochemical blood substitutes: Circulatory and biomedical applications. Clin Hemorheol 1992; 12: 141–56.

Mattrey R. F. Perfluorooctylbromide: A new contrast agent for CT, sonography, and MR imaging. Am J Radiol 1989; 152: 247–52.

Long D M Long D C Mattrey R F . An overview of perfluoroctylbromide – application as a synthetic oxygen carrier and imaging agent for X-ray, ultrasound and nuclear magnetic resonance. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 411–20.

Mattrey R F Hilpert P L Long C D Long D M Mitten R M Peterson T. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs. Crit Care Med 1989; 17: 652–56.

Braun R D Linsenmeier R A Goldstick T. K. New perfluorocarbon emulsion improves tissue oxygenation in cat retina. J Appl Physiol 1992; 72: 1960–68.

Tsai A G Nolte D. Messmer K. Intaglietta M. Effect of Oxygent™ (Perflubron emulsion) on leukocyte–endothelial interaction in postcapillary venules. Biomater Artif Cells Immobil Biotechnol 1992; 20: 959–61.

Davis S S Hadgraft J. Palin K. J. Medical and pharmaceutical applications of emulsions. In: Becher P. ed. Encyclopedia of emulsion technology, vol 2. New York: Marcel Dekker, 1985: 159–238.

Mukerji B. Sloviter H. A. A stable perfluorochemical blood substitute. Transfusion 1991; 31: 324–26.

Sharma S K Bollands A D Davis S S Lowe K. C. Emulsified perfluorochemicals as physiological oxygen-transport fluids: Assessment of a novel formulation. In: Silver I A Silver A. eds. Oxygen transport to tissue, Vol IX. London: Plenum, 1987: 97–108.

Sharma S K Lowe K C Davis S. S. Novel compositions of emulsified perfluorochemicals for biological uses. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 447–50.

Bollands A D Lowe K C Sharma S K Davis S. S. Lymphoid tissue responses to a novel perfluorochemical emulsion in rats. J Pharm Pharmacol 1987; 39: 1021–24.

Bollands A D Lowe K C Sharma S K Davis S. S. Biocompatibility studies with a novel perfluorochemical emulsion. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 451–53.

Lowe K C Bollands A D Raven P. D. Effects of a novel perfluorochemical emulsion on lymphoid tissues and immunocompetence in rats: Time course effects relative to immune challenge. Comp Biochem Physiol 1989; 93C: 377–80.

Johnson O L Washington C. Davis S. S. Thermal stability of fluorocarbon emulsions that transport oxygen. Int J Pharm 1990; 59: 131–35.

Johnson O L Washington C. Davis S. S. Long-term stability studies of fluorocarbon oxygen transport emulsions. Int J Pharm 1990; 63: 65–72.

Bentley P K Johnson O L Washington C. Lowe K. C. Lymphoid tissue responses to concentrated perfluorochemical emulsions in rats. Biomater Artif Cells Immobil Biotechnol 1992; 20: 1033–36.

Bentley P K Johnson O L Washington C. Lowe K. C. Uptake of concentrated perfluorochemical emulsions into rat lymphoid tissues. J Pharm Pharmacol 1993; 45: 182–85.

Thomas C. De Vathaire F L Lartigau E. Malaise E P Guichard M. Radiosensitivity of mouse lip mucosa: Influence of anesthesia, carbogen, and a new high O2 carrying perfluorochemical emulsion. Radiat Res 1989; 118: 476–87.

Lartigau E. Thomas C. Le Blanc M. . New high O2 carrying perfluorochemical emulsions: Toxicity, radiosensitivity of GM–CFC and development of metastases in mice. Int J Radiat Oncol Biol Phys 1989; 16: 1153–56.

Mitsuno T. Ohyanagi H. Yokoyama K. Suyama T. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 365–73.

Ohyanagi H. Saitoh Y. Mitsuno T. Watanabe K. Yamanouchi K. Yokoyama K. A new perfluorochemical emulsion: An overview. Artif Org 1990; 14: 199–200.

Uchida T. Ohtaki Y. Kido M. Watanabe K. Yokoyama K. Protective effect of FMIQ emulsion coronary perfusion on a myocardial ischaemia model in an anesthetized open-chest dog. In: Sekiguchi S. ed. Proceedings of the 2nd International Symposium on Red Cell Substitutes. Tokyo: Kindai Shuppan, 1991: 2–4.

Rockwell S. Kelley M. Irvin C. G. Effects of the perfluorochemical emulsion FMIQ on the radiation response of EMT6 tumours. Int J Radiat Oncol Biol Phys 1992; 61: 833–39.

Grover F L Heron W H Newman M M Paton B. C. Effects of a non-ionic surface active agent on blood viscosity and platelet adhesiveness. Circulation 1969; 39 (suppl I): I–249.

Carter C. Fisher T C Hamai H. . Haemorheological effects of a non-ionic copolymer surfactant (Poloxamer 188). Clin Hemorheol 1992; 12: 109–20.

Bentley P K Davis S S Johnson O L Lowe K C Washington C. Purification of Pluronic F-68 for perfluorochemical emulsification. J Pharm Pharmacol 1989; 41: 661–63.

Mahe A M Manoux J. Valla A. . Perfluoroalkylated surfactants: Relationships between structure and acute toxicity in mice. Biomater Artif Cells Immobil Biotechnol 1992; 20: 1025–27.

Yokoyama K. Watanabe M. Naito R. Retention of perfluorochemicals (PFCs) in blood of human recipients after infusion of Fluosol-DA 20%. In: Frey R. Beisbarth H. Stosseck K. eds. Oxygen-carrying colloidal blood substitutes. Munich: Zuckschwerdt, 1982: 214–19.

Lutz J. Stark M. Half-life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats. Pflügers Arch 1987; 410: 181–84.

Tsuda Y. Yamanouchi K. Yokoyama K. . Discussion and considerations for the excretion mechanism of perfluorochemical emulsion. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 473–83.

Nanney L. Fink L M Virmani R. Perfluorochemicals: Morphologic changes in infused liver, spleen, lung and kidney of rabbits. Arch Pathol Lab Med 1984; 108: 631–37.

Kitazawa M. Ohnishi Y. Long term experiment of perfluorochemicals using rabbits. Virchows Arch 1982; 398: 1–10.

Lowe K. C. Emulsified perfluorochemicals for oxygen-transport to tissues: Effects on lymphoid system and immunological competence. In: Mochizuki M. Honig C. Koyama T. Goldstick T K Bruley D F eds. Oxygen transport to tissue, Volume X. New York: Plenum, 1990: 655–65.

Pfannkuch F. Schnoy N. Ohlschlegel C. Wilson C. Comparative morphological studies in animal experiments after parenteral use of Fluosol®–43, -DA 20% and -DA 35%. In: Frey R. Beisbarth H. Stosseck K. eds. Oxygen-carrying colloidal blood substitutes. Munich: Zuckschwerdt, 1982: 61–67.

Lutz J. Effect of perfluorochemicals on host defence, especially on the reticuloendothelial system. In: Tremper K. ed. Perfluorochemical oxygen transport. Boston: Little Brown, 1985: 63–93.

Lowe K. C. Biological assessment of perfluorochemical emulsions. In: Lowe K C ed. Blood substitutes: Preparation, physiology and medical applications. Chichester: Ellis Horwood, 1988: 149–72.

Castro O. Nesbitt A E Lyles D. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function. Am J Hematol 1984; 16: 15–21.

Lutz J. Augustin A J Schwegler J S Milz J. Magnetometric studies on the reticulo-endothelial system of the liver after administration of different lipid emulsions. Life Sci 1992; 50: 1503–10.

Bottalico L A Betensky H T Min Y B Weinstock S. Perfluorochemical emulsions decrease Kupffer cell phagocytosis. Hepatology 1991; 14: 169–74.

Bollands A D Lowe K. C. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissues and immunological competence. Comp Biochem Physiol 1986; 85C: 309–12.

Bollands A D Lowe K. C. Lymphoid tissue responses to perfluorocarbon emulsion in mice. Comp Biochem Physiol 1987; 86C: 431–35.

Bollands A D Lowe K. C. Lymphoid tissue responses to perfluorocarbon emulsion in rats: Time course effects relative to immune challenge. Comp Biochem Physiol 1988; 89C: 127–32.

Lowe K C Bollands A. D. Lymphoid tissue responses to emulsified perfluorochemicals: Comparative aspects. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 495–504.

Armstrong F H Lowe K. C. Effects of emulsified perfluorochemicals on liver cytochromes P-450 in rats. Comp Biochem Physiol 1989; 94C: 345–49.

Armstrong F H Lowe K. C. Effects of emulsified perfluorochemicals on liver aryl esterase in rats. Comp Biochem Physiol 1991; 99C: 561–65.

Lowe K C Armstrong F. H. Biocompatibility studies with perfluorochemical oxygen carriers. Biomater Artif Cells Immobil Biotechnol 1992; 20: 993–99.

Ravis W R Ramakanth S. Brzozowski D M Hamrick M. E. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system. J Pharm Pharmacol 1992; 44: 219–23.

Lowe K C Washington C. Alternative blood substitutes. Nature 1992; 358: 717–18.

Shrewsbury R P White L. G. Some insights into the variations in antipyrine pharmacokinetics in the rat. Res Commun Chem Pathol Pharmacol 1988; 62: 137–40.

Ravis W R Hoke J F Parsons D. L. Perfluorochemical erythrocyte substitutes: Disposition and effects on drug distribution and elimination. Drug Metab Rev 1991; 23: 375–411.

Shrewsbury R. P. Acute effects of moderate Fluosol-DA hemodilution on hepatic microsomal and nonmicrosomal metabolism in rats. Biomater Artif Cells Immobil Biotechnol 1992; 20: 1037–43.

Faithfull N. S. Oxygen delivery from fluorocarbon emulsions – aspects of convective diffusion and diffusive transport. Biomater Artif Cells Immobil Biotechnol 1992; 20: 797–804.

Lowe K. C. Novel approaches to the management of ischaemic tissues using synthetic oxygen carriers. In: Messmer K. ed. Ischemic diseases and the microcirculation – new results. Munich: Zuckschwerdt, 1989: 100–107.

Forman M B Puett D W Wilson B H Vaughn W K Friesinger G C Virmani R. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model. J Am Coll Cardiol 1987; 9: 1082–90.

Forman M B Puett D W Bingham S E . Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1987; 76: 469–79.

Kolodgie F D Virmani R. Farb A. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%). J Am Coll Cardiol 1991; 18: 215–23.

Forman M B Ingram D A Murray J. J. Attenuation of myocardial reperfusion injury by perfluorochemical emulsions. Clin Hemorheol 1992; 12: 121–40.

Bajaj A K Cobb M A Virmani R. Gay J C Light R T Forman M. B. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation. Circulation 1989; 79: 645–56.

Lowe K. C. Synthetic oxygen transport fluids based on perfluorochemicals: Applications in medicine and biology. Vox Sang 1991; 60: 129–40.

Lowe K. C. Perfluorocarbons as oxygen-transport fluids. Comp Biochem Physiol 1987; 87A: 825–38.

Peerless S J Nakamura R. Rodriguez-Salazar A. Hunter I. G. Modification of cerebral ischemia with Fluosol. Stroke 1985; 16: 38–43.

Suzuki J. Fujimoto S. Mizoi K. Oba M. The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 1984; 15: 672–79.

Naruse S. Horikawa Y. Tanaka C. Hirakawa K. Nishikawa H. Watari H. Measurements of in vivo energy metabolism in experimental cerebral ischemia using 31P-NMR for the evaluation of protective effects of perfluorochemicals and glycerol. Neurol Res 1984; 6: 169–75.

Osterholm J L Alderman J B Triolo A J D'Amore B R Williams H. D. Severe cerebral ischemia treatment by ventriculo-subarachnoid perfusion with an oxygenated fluorocarbon emulsion. Neurosurgery 1983; 13: 381–87.

Osterholm J L Alderman J B Triolo A J D'Amore B R Williams H. D. Oxygenated fluorocarbon nutrient solution in the treatment of experimental spinal cord injury. Neurosurgery 1984; 15: 373–80.

Bose B. Osterholm J L Triolo A. J. Focal cerebral ischemia: Reduction in size of infarcts by ventriculo-subarachnoid perfusion with fluorocarbon emulsion. Brain Res 1984; 328: 223–31.

Bose B G Osterholm J L Payne J B Chambers K. Preservation of neuronal function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion. Neurosurgery 1986; 18: 270–76.

Triolo A J Osterholm J L Alexander G M Bell R D Frazer G. D. Local cerebral glucose metabolism after global ischemia: Treatment by ventriculocisternal perfusion with a fluorocarbon emulsion. Neurosurgery 1990; 26: 480–88.

Handa H. Nagasawa S. Yonekawa Y. Naruo Y. Oda Y. New treatment of cerebral vasospasm with Fluosol-DA 20%: Protective effect on cerebral ischemia and change of cerebral blood flow. In: Bolin R B Geyer R P Nemo C J eds. Advances in blood substitute research. New York: Liss, 1983: 299–306.

DelRossi A J Cernaianu A C Cilley J H . Protective effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. Preliminary results in a dog model. J Thor Cardiovasc Surg 1990; 99: 665–69.

Gruentzig A. R. Transluminal dilatation of coronary artery stenosis. Lancet 1978; i: 263.

Spears J R Serur J. Baim D S Grossman W. Paulin B. Myocardial protection with Fluosol-DA during prolonged balloon occlusion in the dog. Circulation 1983; 68 (suppl III): III–80.

Anderson H V Leimgruber P P Roubin G S Nelson D L Gruentzig A. R. Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty. Am Heart J 1985; 110: 720–26.

Anderson H V Nelson D L Leimgruber P P Roubin G S Gruentzig A. R. Coronary artery perfusion during percutaneous transluminal coronary angioplasty. In: Murawski M. Peetoom F. eds. Transfusion medicine: Recent technological advances. New York: Liss, 1986: 3–20.

Cleman M. Jaffe C C Wohlgelernter D. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol-DA 20%. Circulation 1986; 74: 555–62.

Jaffe C C Wohlgelernter D. Highman H A Cleman M. Oxygenated Fluosol-DA 20% distal infusion during coronary angioplasty protects myocardial function. In: Murawski M. Peetoom F. eds. Transfusion medicine: Recent technological advances. New York: Liss, 1986: 21–27.

Roberts C S Anderson H V Carboni A A . Usefulness of intracoronary infusion of fluorocarbon distal to prolonged coronary occlusion by angioplasty balloon in dogs. Am J Cardiol 1986; 57: 1202–205.

Tokika H. Miyazaki A. Fung P. . Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions. Circulation 1987; 75: 473–81.

Virmani R. Kolodgie F D Osmialowski A. Zimmerman P. Mergner W. Forman M. B. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion. Am Heart J 1988; 116: 421–31.

Cowley M J Snow F R SiSiascio G. Kelly K. Guard C. Nixon J. V. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients. Circulation 1990; 81 (suppl IV): 27–34.

Kent K M Cleman M W Cowley M J . Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. Am J Cardiol 1990; 66: 279–84.

Bell M R Nishimura R A Holmes D R Bailey K R Schwartz R S Vlietstra R. E. Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty? J Am Coll Cardiol 1990; 16: 959–66.

Forman M B Perry J M Wilson B H . Demonstration of myocardial reperfusion injury in humans: Results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol 1991; 18: 911–18.

Ogilby J D Noma S. DiLoretto G. Stets G. Preservation of myocardial function during ischemia with intracoronary perfluorooctylbromide. Biomater Artif Cells Immobil Biotechnol 1992; 20: 973–77.

Rockwell S. Perfluorochemical emulsions are adjuncts to radiotherapy. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 519–31.

Teicher B A McIntosh-Lowe N L Rose C. M. Effect of various oxygenation conditions and Fluosol®-DA on cancer chemotherapeutic agents. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 533–46.

Teicher B. A. Use of perfluorochemical emulsions in cancer therapy. Biomater Artif Cells Immobil Biotechnol 1992; 20: 875–82.

Rose C M Lustig R A McIntosh N L Teicher B. A. A clinical trial of Fluosol-DA in advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1986; 12: 1325–27.

Lustig R A Rose C M McIntosh-Lowe N. L. Fluosol®-DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 511–18.

Dowling S. Fischer J J Rockwell S. Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: A pilot study. Biomater Artif Cells Immobil Biotechnol 1992; 20: 903–905.

Chaplin D J Horsman M R Aoki D. S. Nicotinamide, Fluosol-DA and carbogen: A strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer 1991; 63: 109–113.

Rockwell S. Kelley M. Irvin G C . Preclinical evaluation of Oxygent™ as an adjunct to radiotherapy. Biomater Artif Cells Immobil Biotechnol 1992; 20: 883–93.

Thomas C. Riess J G Guichard M. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity. Int J Radiat Biol 1991; 59: 433–45.

Herman T S Teicher B. A. Enhancement of fractionated radiation therapy by an experimental concentrated perflubron (Oxygent®) emulsion in the Lewis lung carcinoma. Biomater Artif Cells Immobil Biotechnol 1992; 20: 899–902.

Holden S A Teicher B A Ha C. Ara G. Herman T S , Enhancement of perflubron emulsion (Oxygent®) and carbogen breathing of the tumor growth delay of the FSAIIC fibrocarcinoma after treatment with antitumor alkylating agents. Biomater Artif Cells Immobil Biotechnol 1992; 20: 895–98.

Thomas C. Lartigau E. Malaise E P Guichard M. New high O2 carrying perfluorochemical emulsions and/or carbogen: Reactions of a human tumor xenograft to irradiation. Int J Radiat Oncol Biol Phys 1989; 16: 1157–60.

Henderson B W Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145–57.

Chowdhary R K Cundall R B Morgan C. G. Influence of fluorocarbon emulsions on porphyrin-sensitised oxidation of histidine. Photochem Photobiol 1990; 51: 395–99.

Fingar V H Mang T S Henderson B. W. Modification of photodynamic therapy-induced hypoxia by Fluosol-DA (20%) and carbogen breathing in mice. Cancer Res 1988; 48: 3350–54.

Berenbaum M C Akande S L Armstrong F H . Perfluorochemicals and photodynamic therapy in mice. In: Piiper J. Goldstick T K Meyer M. eds. Oxygen transport to tissue, Volume XII. New York: Plenum, 1990: 277–82.

Lowe K C Akande S L Bonnett R. White R D Berenbaum M. C. Protective effects of a novel perfluorochemical emulsion in photodynamic therapy. Biomater Artif Cells Immobil Biotechnol 1992; 20: 925–27.

Ceckler T L Gibson S L Hilf R. Bryant R. G. In situ assessment of tumor vascularity using fluorine NMR imaging. Magn Reson Med 1990; 13: 416–33.

Mattrey R F Brown J F Shelton R E Ogino M T Johnson K K Mitten R. M. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography: Safety and efficacy. Invest Radiol 1991; 26: 792–98.

Brown J J Duncan J R Heiken J P . Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: Use with and without glucagon. Radiology 1991; 181: 455–60.

Mattrey R F Schumaker D J Tran H T Guo Q. Buxton R. B. The use of Imagent®-BP in diagnostic imaging research and 19F magnetic resonance for pO2 measurements. Biomater Artif Cells Immobil Biotechnol 1992; 20: 917–20.

Pratt R G Thomas S R Millard R W Samaratunga R C Naseem M. H. Quantitation of perfluorocarbon blood substitutes in tissues using F-19 magnetic resonance spectroscopy. Biomater Artif Cells Immobil Biotechnol 1992; 20: 921–24.

Wilson C A Berkowitz B A McCuen B W Charles H. C. Measurement of preretinal oxygen tension in the vitrectomized human eye using fluorine-19 magnetic resonance spectroscopy. Arch Ophthalmol 1992; 110: 1098–100.

André M. Nelson T. Mattrey R. F. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent. Invest Radiol 1990; 25: 983–87.

Munzing D. Mattrey R F Reznik V M Mitten R M Peterson T. Potential role of PFOB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necroses. Kidney Int 1991; 39: 733–39.

Coley B D Mattrey R F Roberts A. Keane S. Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction. Kidney Int 1991; 39: 740–45.

Lutz J. Herrman G. Perfluorochemicals as a treatment of decompression sickness in rats. Pflügers Arch 1984; 401: 174–77.

Spiess B D McCarthy R J Tuman K J Woronowicz A W Tool K A Ivankovich A. D. Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). Undersea Biomed Res 1988; 15: 31–37.

Widjaja B. Wuthe J. Schmidt A. Seitz B. Rufer R. Mechanical properties of isolated fetal miniature pig lungs after substitution with fluorocarbons. Res Exp Med 1988; 188: 425–32.

Wolfson M R Shaffer T. H. Liquid ventilation during early development: Theory, physiologic processes and application. J Dev Physiol 1990; 13: 1–12.

Clark L C Hoffman R E Davis S. L. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes. Biomater Artif Cells Immobil Biotechnol 1992; 20: 1085–99.

Curtis S E Fuhrman B P Howland D F DeFrancisis M. Motoyama E. K. Cardiac output during liquid (perfluorocarbon) breathing in newborn piglets. Crit Care Med 1991; 19: 225–30.

Lowe C. Tuma R F Sivieri E M Shaffer T. H. Liquid ventilation: Cardiovascular adjustments with secondary hyperlactatemia and acidosis. J Appl Physiol 1979; 47: 1051–57.

Greenspan J S Wolfson M R Rubenstein S D Shaffer T. H. Liquid ventilation of preterm baby. Lancet 1989; ii: 1094.

Greenspan J S Wolfson M R Rubenstein S D Shaffer T. H. Liquid ventilation of human preterm neonates. J Pediatr 1990; 117: 106–11.

Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987; 103: 38–43.

Chang S. Reppucci V. Zimmerman N J Heinemann M-H Coleman D. J. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology 1989; 96: 785–92.

Blinder K J Peyman G A Paris C L . Vitreon, a new perfluorocarbon. Br J Ophthalmol 1991; 75: 240–44.

Gremillion C M Peyman G A Liu K R Naguib K. S. Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 1990; 74: 643–46.

Folk J C Packer A J Weingeist T A Howcroft M. J. Sodium hyaluronate (Healon) in closed vitrectomy. Ophthalmol Surg 1986; 17: 299–304.

Glaser B M Carter J B Kuppermann B D Michels R. G. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology 1991; 98: 1613–21.

Kreiger A E Lewis H. Management of giant retinal tears without scleral buckling. Use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade. Ophthalmology 1992; 99: 491–97.

Lopez R. Chang S. Longterm results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathy. Am J Ophthalmol 1992; 113: 424–28.

Haller J A Campochiaro P. A. Oil and gas on troubled waters. Arch Ophthalmol 1992; 110: 768–69.

The Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Silicone study report 1. Arch Ophthalmol 1992; 110: 770–79.

The Silicone Study Group. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Silicone study report 2. Arch Ophthalmol 1992; 110: 780–92.

Shapiro M J Resnick K I Kim S H Weinberg A. Management of the dislocated crystalline lens with a perfluorocarbon liquid. Am J Ophthalmol 1991; 112: 401–405.

Rowson N J Bacon A S Rosen P. H. Perfluorocarbon heavy liquids in the management of posterior dislocation of the lens nucleus during phacoemulsification. Br J Ophthalmol 1992; 76: 169–70.

Gollan F. Clark L. C. Organ perfusion with fluorocarbon liquid. Physiologist 1966; 9: 191.

Sloviter H A Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967; 216: 458–60.

Ferrari M. Hanley D F Wilson D A Traystman R. J. Redox changes in cat brain cytochrome c oxidase after blood–fluorocarbon exchange. Am J Physiol 1990; 258: H1706–H1713.

Harvey S A K Trankina M L Olson M S Clark J. B. Fluorocarbon perfusion of the isolated rat brain: Measurement of tissue spaces, EEG and oxygen uptake. Biochim Biophys Acta 1991; 1073: 486–92.

Thoreson W B Purple R. L. Effects of using the oxygen-carrying fluorocarbon, FC43, on the ERG of the arterially perfused cat eye. Curr Eye Res 1989; 8: 487–98.

Kyosola K. Harjula A. Mattila S. . Cardioplegic protection with hypothermic K-Fluosol-DA and K/Mg-Fluosol-DA solutions. Scand J Thorac Cardiovasc Surg 1985; 19: 267–72.

Ueda K. Genda T. Hirata I. . Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart. J Heart Lung Transplant 1992; 11: 646–55.

Rahamathulla P M Watanabe K. Ashraf M. Millard R. W. Prevention of lactate production and myocyte injury in isolated rat hearts perfused with perfluorochemical emulsion. Exp Pathol 1985; 28: 157–65.

Segel L D Ensunsa J. L. Albumin improves stability and longevity of perfluorochemical-perfused hearts. Am J Physiol 1988; 254: H1105–H1112.

Fuchinoue S. Takahashi K. Teraoka S. Toma H. Ashishi T. Ota K. Clinical experience in kidney preservation with a new fluorocarbon emulsion perfusate. Transplant Proc 1986; 18: 566–70.

Branca D. Scutari G. Siliprandi N. Vincent E. Gambaretto G. Evaluation of some mitochondrial functions following liver perfusion with perfluorotributylamine emulsions. Biochem Pharmacol 1988; 37: 2479–81.

Palombo J D Pomposelli J J Fechner K D Blackburn G L Bistrian B. R. Enhanced restoration of adenine nucleotides in rat liver following extended preservation in UW solution by provision of adenosine during reperfusion. Transplantation 1991; 51: 867–73.

Felker T E Gantz D. Tercyak A M Oliva C. Clark S B Small D. M. A comparison of lipoprotein secretion, bile production and hepatic morphology in isolated rat livers, perfused with a perfluorocarbon emulsion or rat erythrocytes. Hepatology 1991; 14: 340–51.

Lindgren L. Marshall C. Marshall B. E. Hypoxic pulmonary vasoconstriction in isolated rat lungs perfused with perfluorocarbon emulsion. Acta Physiol Scand 1985; 123: 335–38.

Kurki T S Harjula A L Heikkila L J . Single-lung allotransplantation in pigs: Effects of two preservation methods on pulmonary gas exchange. J Heart Transplant 1990; 9: 424–28.

Ohyanagi H. Ohashi O. Nakayama S. Yamamoto M. Okumura S. Saitoh Y. Experimental studies on Fluosol-DA administration in acute pancreatitis. In: Chang T M S Geyer R P eds. Blood substitutes. New York: Marcel Dekker, 1989: 585–94.

O'Malley V P Keyes D M Postier R. G. The Fluosol-perfused isolated canine pancreas: A model for the study of blood component effects in acute pancreatitis. J Surg Res 1986; 40: 210–15.

Chubb C. Draper P. Steroid secretion by rat testes perfused with perfluorochemicals as oxygen carriers. Am J Physiol 1985; 248: E432–E437.

Chubb C. Draper P. Efficacy of perfluorodecalin as an oxygen carrier for mouse and rat testes perfused in vitro. Proc Soc Exp Biol Med 1987; 184: 489–94.

Urushihara T. Sumimoto K. Ikeda M. . A comparison study of rat pancreas preservation using perfluorochemical and fluorocarbon-emulsion as preservation medium. Biomater Artif Cells Immobil Biotechnol 1992; 20: 933–37.

Smith A R Van Alphen W. Faithfull N S Fennema M. Limb preservation in replantation surgery. J Plastic Reconstr Surg 1985; 75: 227–37.

Kawamura T. Kuroda Y. Suzuki Y. Fujiwara H. Yamamoto K. Saitoh Y. A new simple two layer (Euro-Collins' solution/perfluorochemical) cold storage method for pancreas preservation. Transplant Proc 1989; 21: 1376–77.

Kuroda Y. Fujino Y. Kawamura T. Suzuki Y. Fujiwara H. Saitoh Y. Mechanism of oxygenation of pancreas during preservation by a two-layer (Euro-Collins' solution/perfluorochemical) cold storage method. Transplantation 1990; 49: 694–96.

King A T Mulligan B J Lowe K. C. Perfluorochemicals and cell culture. Bio/Technology 1989; 7: 1037–42.

Giaever I. Keese C. R. Behaviour of cells at fluid interfaces. Proc Natl Acad Sci USA 1983; 80: 219–22.

Nabih M. Peyman G A Clark L C . Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: A preliminary report. Ophthalmol Surg 1989; 20: 286–93.